Cytokinetics, Inc. (CYTK)
65.32
-0.16
(-0.24%)
USD |
NASDAQ |
Apr 24, 16:00
64.50
-0.82
(-1.26%)
After-Hours: 20:00
Cytokinetics Market Cap : 8.045B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 119.87B |
| Regeneron Pharmaceuticals, Inc. | 79.46B |
| AtriCure, Inc. | 1.458B |
| Johnson & Johnson | 547.64B |
| Edgewise Therapeutics, Inc. | 3.388B |
Market Cap Related Metrics
| PS Ratio | 89.10 |
| PEG Ratio | -0.4201 |
| Price | 65.32 |
| Earnings Yield | -10.00% |
| PEGY Ratio | -0.4201 |